Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Tissue Culture Innovations · Predicate Candidate Screening

6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

9 daysmedian FDA review time
9 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K860787DULBECCO'S MEMTissue Culture Innovations1986-03-1290
K860784DULBECCO'S PHOSPHATE BUFFERED SALINE W/CALCL2Tissue Culture Innovations1986-03-1290
K860786RPMI 1640 HEPESTissue Culture Innovations1986-03-1290
K860785HAM'S F-12 W/NAHCO3Tissue Culture Innovations1986-03-1290
K860783MICRO CARRIERTissue Culture Innovations1986-03-1290
K860788HAM'S F-12 W/GLUTAMINE & NAHCO3Tissue Culture Innovations1986-03-1290

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda